IL1B and type 2 diabetes mellitus: Since interleukin-1β (IL-1β) has been reported as a key player in the development of T2D and diabetic cardiovascular complications, we employed IL-1β to induce endothelial cell dysfunction in the following in vitro studies [31,33,34].